Koyfin Home > Directory > Health Care > Apellis Pharmaceuticals Inc > Net Income

Apellis Pharmaceuticals Inc Net Income Chart (APLS)

Apellis Pharmaceuticals Inc annual/quarterly Net Income from 2017 to 2018. Net income is calculated as sales less cost of goods sold, selling, general and administrative expenses, operating expenses, depreciation, interest, taxes and other expenses. This number appears on a company's income statement and is an important measure of how profitable the company is.
  • Apellis Pharmaceuticals Inc Net Income for the quarter ending December 12, 2018 was $-36m a 40.38% decrease of -15m year over year
  • Apellis Pharmaceuticals Inc Net Income for the last 12 months ending December 12, 2018 was $-128m a 50.05% decrease of -64m year over year
  • Apellis Pharmaceuticals Inc Annual Net Income for 2018 was $-128m a 60.00% decrease of -76m from 2017
  • Apellis Pharmaceuticals Inc Annual Net Income for 2017 was $-51m a 46.82% decrease of -24m from 2016
  • Apellis Pharmaceuticals Inc Annual Net Income for 2016 was $-27m a -71.49% increase of 19m from 2015
Other Income Statement Metrics:
  • Apellis Pharmaceuticals Inc EBITDA for the quarter ending December 12, 2018 was $-37m a 42.92% decrease of -16m year over year
View Chart On Koyfin

Quarterly APLS Net Income Data

12/2018$-36m
09/2018$-36m
06/2018$-33m
03/2018$-22m
12/2017$-18m
09/2017$-12m
06/2017$-12m

Annual APLS Net Income Data

2018$-128m
2017$-51m
2016$-27m
2015$-47m